
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neur... Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.3637 | 5.08934693478 | 7.1463 | 7.79 | 6.915 | 681990 | 7.34511907 | CS |
4 | -0.02 | -0.265604249668 | 7.53 | 8.7451 | 6.915 | 727263 | 7.80195606 | CS |
12 | -2.09 | -21.7708333333 | 9.6 | 10.52 | 6.56 | 1300091 | 8.04951771 | CS |
26 | -4.74 | -38.693877551 | 12.25 | 13.48 | 6.56 | 903750 | 9.02651216 | CS |
52 | -11.17 | -59.7965738758 | 18.68 | 28.8 | 6.56 | 752200 | 12.09979462 | CS |
156 | -16.96 | -69.309358398 | 24.47 | 35.73 | 6.56 | 531414 | 17.05566014 | CS |
260 | -46.18 | -86.012292792 | 53.69 | 54.58 | 6.56 | 482291 | 23.59953755 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約